Skip to main content

Publication, Part of

NICE Technology Appraisals in the NHS in England (Innovation Scorecard) To June 2021

Official statistics

Current Chapter

NICE Technology Appraisals in the NHS in England (Innovation Scorecard) To June 2021


Summary

The Innovation Scorecard reports on the use of medicines and medicine groupings in the NHS in England, which have been positively appraised by the National Institute for Health and Care Excellence (NICE).

NHS Digital has produced and published the Innovation Scorecard as an Official Statistic since January 2013 on behalf of the Office for Life Sciences. It can be used by local NHS organisations to monitor progress in implementing NICE Technology Appraisal (TA) recommendations.

We produce the scorecard using a range of data sources prior to publication and no central data collection is involved.

This publication is the second in the series to use the Secondary Care Medicines data that is supplied by Rx-Info and now published by the NHS BSA through their open data portal to provide a richer source of data down to hospital Trust level. This data is not directly comparable with the secondary care data used in previous publications due to variations in the coverage and completeness and changes in some of the prescribing measures used to present volume of use in this publication.

The estimates report was delayed due to a data quality issue. It was published on Monday 1st November. We apologise for any inconvenience caused.


Medicines

166 medicines reported on, 99% of 149 medicines prescribed more *

Medicines are those reported on the Innovation Scorecard only

Medicine Groupings

9 medicine groupings used to treat major conditions, 9 medicine groupings were used more *

Medicine groupings are those reported on the Innovation Scorecard only

those medicines with data for each of the latest 8 quarters comparing the 12 months from July 2020 to June 2021 (to the previous 12 months)

Reported as Defined Daily Doses (DDD), Actual Daily Doses (ADD), mgs, vials, tablets, units, implants, pads, interventions or pens/syringes per 100,000 population or QOF register in England

Conditions covered by medicine groupings:

  • Acute Coronary Syndrome
  • Cystic Fibrosis
  • Diabetes
  • Hepatitis C
  • Multiple Sclerosis
  • Severe Asthma
  • Smoking Cessation
  • Stroke (Separate medicine groupings for stroke by care setting i.e. GP and hospital, DOAC Primary and DOAC Secondary)

Source: NHS Digital


Administrative Sources

• English Prescribing Dataset (EPD) published by the NHS Business Services Authority • Secondary Care Medicines Data (SCMD) published by the NHS Business Services Authority • Hospital Episode Statistics (HES) and Quality Outcomes Framework (QOF) data from NHS Digital • Mid-year population estimates from Office for National Statistics




Last edited: 1 November 2021 4:25 pm